Suzanne Shusterman
Impact in
- Neurology top 2%
- Neuroblastoma Research and Treatments
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
- Neurology 29
- Neuroblastoma Research and Treatments 29
-
- Pharmaceutical studies and practices 5
- Co-authors
- John M. Maris (15 shared papers)Lisa Diller (7 shared papers)Wendy B. London (8 shared papers)Julia Glade Bender (6 shared papers)Steven G. DuBois (11 shared papers)Anna T. Meadows (1 shared paper)Peter C. Adamson (4 shared papers)Paul M. Sondel (3 shared papers)
- Journals
- Pediatric Blood & Cancer (5 papers)Journal of Clinical Oncology (5 papers)Cancer Medicine (4 papers)Clinical Cancer Research (4 papers)Cancer (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Suzanne Shusterman
54 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 83
- Neurology 760
- Cancer Research 206
- Oncology 283
- Immunology 245
- Genetics 87
Countries citing papers authored by Suzanne Shusterman
This map shows the geographic impact of Suzanne Shusterman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne Shusterman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne Shusterman more than expected).
Fields of papers citing papers by Suzanne Shusterman
This network shows the impact of papers produced by Suzanne Shusterman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne Shusterman. The network helps show where Suzanne Shusterman may publish in the future.
Co-authors
The 25 scholars most cited alongside Suzanne Shusterman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 203 | |
| 2 | 2016 | 180 | |
| 3 | 2006 | 163 | |
| 4 | 2010 | 152 | |
| 5 | 2015 | 150 | |
| 6 | 2011 | 104 | |
| 7 | 2011 | 102 | |
| 8 | 2009 | 99 | |
| 9 | 2023 | 92 | |
| 10 | 2022 | 84 | |
| 11 | The angiogenesis inhibitor tnp-470 effectively inhibits human neuroblastoma xenograft growth, especially in the setting of subclinical disease. | 2001 | 80 |
| 12 | 2011 | 79 | |
| 13 | Evidence for a hereditary neuroblastoma predisposition locus at chromosome 16p12-13. | 2002 | 62 |
| 14 | 2021 | 62 | |
| 15 | 2000 | 51 | |
| 16 | 2019 | 43 | |
| 17 | 2005 | 42 | |
| 18 | 2020 | 42 | |
| 19 | 2022 | 37 | |
| 20 | 2012 | 33 |
About Suzanne Shusterman
Suzanne Shusterman is a scholar working on Neurology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health, Hematology and Molecular Biology, having authored 56 papers that have together received 2.3k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (29 papers), Pharmaceutical studies and practices (5 papers), Cancer therapeutics and mechanisms (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Sarcoma Diagnosis and Treatment (3 papers), Palliative Care and End-of-Life Issues (3 papers), Acute Lymphoblastic Leukemia research (3 papers) and Palliative and Oncologic Care (2 papers). The work is most often cited by research in Neurology (760 citations), Cancer Research (206 citations), Oncology (283 citations), Immunology (245 citations) and Genetics (87 citations). Suzanne Shusterman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include John M. Maris, Lisa Diller, Wendy B. London, Julia Glade Bender, Steven G. DuBois, Anna T. Meadows, Peter C. Adamson, Paul M. Sondel, Stephan A. Grupp and Jacek Gan. Their work appears in journals such as Pediatric Blood & Cancer, Journal of Clinical Oncology, Cancer Medicine, Clinical Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.